The Clinical Effect of Hip Protection Orthosis for the Hip Protection of Hip Dislocation in Patients With Severe Neuromuscular Disease, Pilot Study
NCT ID: NCT04483050
Last Updated: 2022-11-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
4 participants
INTERVENTIONAL
2020-02-05
2021-03-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Clinical Efficacy of Hip Protection Orthosis for the Protection of Hip Dislocation
NCT04033289
Muscle Activity With the Use of Ankle Foot Orthoses in Cerebral Palsy
NCT00462085
Efficacy of New Protocols in the Treatment of Upper Limb Dysfunctions in Patients With Cerebral Palsy
NCT03048851
Application of 3D Scanner to Measure Physical Size in Patients With Severe Cerebral Palsy
NCT05388422
Effect of Vibration Therapy on Hip Girdle Muscles in Healthy People
NCT05831904
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
experimental group
Hip protection orthosis
Experimental group would wear hip protection orthosis over 12 hours a day for 1 year.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hip protection orthosis
Experimental group would wear hip protection orthosis over 12 hours a day for 1 year.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with severe neuromuscular disease
* Patients who agreed to participate in the study
* Hip dislocation more than 10% (migration index)
Exclusion Criteria
* Those who are determined to be difficult to participate under the judgment of the research director
* History of hip joint surgery
1 Year
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Korea Health Industry Development Institute
OTHER_GOV
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ju Seok Ryu
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Juseok Ryu, PhD
Role: STUDY_DIRECTOR
Seoul National University Bundang Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Bundang Hospital
Gyeonggi-do, Seongnam-si, Gyeonggi-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B-2002/594-305
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.